Levure de riz rouge
Food supplement declared in France, declaration No 2017-4-829, decision dated 28 April 2017
Levure de riz rouge is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- CORHALI
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 Gélules par jour
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Enfants (moins de 12 ans), Femmes enceintes, Insuffisance rénale, Nourrissons (moins de 1 an), Problèmes de foie
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol
Declaration 280551, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/860).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Monascus purpureus Went | Mycélium | Poudre (de plantes séchées ou broyées) | 600 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Déconseiller aux enfants, femmes enceintes ou allaitant , aux hémostatiques ainsi que cas de troubles hépatiques ou rénaux.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.